In addition to functional significance and therapeutic implication, P. gingivalis abundance itself and P. gingivalis-associated dysregulated components of GARP/TGFβ-dependent Smads/YAP/TAZ pathways offer novel biomarker sets to predict the clinical outcome of ESCC patients. This evidence concerns the gene YAP1 and esophageal squamous cell carcinoma.